Singlera Genomics

Categories

Description

Provides molecular diagnostic technology for early cancer detection and genetic disease analysis.

Summary

Singlera Genomics specializes in liquid biopsy and cancer early detection technologies, offering a wide range of products for cancer early screening, diagnosis, and prognostic monitoring. Their focus on methylation detection technology aids in the risk assessment, early screening, medication guidance, and recurrence monitoring of various high-incidence cancers. With a commitment to innovation and collaboration, Singlera Genomics is a key player in the global effort to advance cancer diagnostics.

Use Cases

• Utilizing liquid biopsy for non-invasive early detection of colorectal cancer.
• Applying methylation detection technology for risk assessment in lung cancer screening.